{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:51:19Z","timestamp":1790113879183,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jlr.2025.100763","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:48:39Z","timestamp":1740185319000},"page":"100763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Foamy monocytes and atherogenesis in mice with combined hyperlipidemia and effects of antisense knockdown of apoCIII"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6886-576X","authenticated-orcid":false,"given":"Xueying","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeqin","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2868-3870","authenticated-orcid":false,"given":"Jing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3636-8724","authenticated-orcid":false,"given":"Benjamin A.","family":"Litchfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yuan Dai","family":"Perrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2527-0966","authenticated-orcid":false,"given":"Timothy","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam E.","family":"Mullick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanne","family":"Crooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J.","family":"Pownall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott I.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6846-5531","authenticated-orcid":false,"given":"Huaizhu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2025.100763_bib1","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1161\/hc5001.100624","article-title":"Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S","volume":"104","author":"Ballantyne","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2025.100763_bib2","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jlr.2025.100763_bib3","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American heart association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2025.100763_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"Jorgensen","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2025.100763_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrcardio.2009.228","article-title":"Monocytes in atherosclerosis: subsets and functions","volume":"7","author":"Woollard","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jlr.2025.100763_bib6","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1161\/CIRCULATIONAHA.108.823740","article-title":"Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia","volume":"119","author":"Wu","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2025.100763_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrcardio.2017.75","article-title":"Dyslipidaemia: PCSK9 inhibitors and foamy monocytes in familial hypercholesterolaemia","volume":"14","author":"Wu","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jlr.2025.100763_bib8","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1161\/ATVBAHA.115.305609","article-title":"Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemia","volume":"35","author":"Xu","year":"2015","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2025.100763_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques","volume":"117","author":"Tacke","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2025.100763_bib10","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41467-018-03351-4","article-title":"MT4-MMP deficiency increases patrolling monocyte recruitment to early lesions and accelerates atherosclerosis","volume":"9","author":"Clemente","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jlr.2025.100763_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrcardio.2017.34","article-title":"Effects of dyslipidaemia on monocyte production and function in cardiovascular disease","volume":"14","author":"Rahman","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jlr.2025.100763_bib12","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm.3258","article-title":"Local proliferation dominates lesional macrophage accumulation in atherosclerosis","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jlr.2025.100763_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/ATVBAHA.119.313078","article-title":"Replacing saturated fat with unsaturated fat in western diet reduces foamy monocytes and atherosclerosis in male Ldlr(-\/-) mice","volume":"40","author":"Lian","year":"2020","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2025.100763_bib14","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/eurheartj\/ehx002","article-title":"PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia","volume":"38","author":"Bernelot Moens","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jlr.2025.100763_bib15","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1210\/jc.2016-2732","article-title":"Postprandial monocyte activation in individuals with metabolic syndrome","volume":"101","author":"Khan","year":"2016","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jlr.2025.100763_bib16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.116.308834","article-title":"Remnant cholesterol elicits arterial wall inflammation and a multilevel cellular immune response in humans","volume":"37","author":"Bernelot Moens","year":"2017","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2025.100763_bib17","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1161\/ATVBAHA.119.312389","article-title":"Role of LpL (lipoprotein lipase) in macrophage polarization in\u00a0vitro and in\u00a0vivo","volume":"39","author":"Chang","year":"2019","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2025.100763_bib18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3945\/ajcn.110.007765","article-title":"A\u00a0high-fat meal promotes lipid-load and apolipoprotein B-48 receptor transcriptional activity in circulating monocytes","volume":"93","author":"Varela","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.jlr.2025.100763_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/ATVBAHA.110.215434","article-title":"CD11c\/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1","volume":"31","author":"Gower","year":"2011","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2025.100763_bib20","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.4049\/jimmunol.0903475","article-title":"Fatty acids from very low-density lipoprotein lipolysis products induce lipid droplet accumulation in human monocytes","volume":"184","author":"den Hartigh","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jlr.2025.100763_bib21","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jacl.2017.08.011","article-title":"Effects of n-3 fatty acid treatment on monocyte phenotypes in humans with hypertriglyceridemia","volume":"11","author":"Dai Perrard","year":"2017","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.jlr.2025.100763_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent Ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2025.100763_bib23","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2337\/db20-0634","article-title":"Deficiency of Stat1 in CD11c(+) cells alters adipose tissue inflammation and improves metabolic dysfunctions in mice fed a high-fat diet","volume":"70","author":"Antony","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.jlr.2025.100763_bib24","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/CIRCRESAHA.111.300367","article-title":"Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans","volume":"112","author":"Graham","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2025.100763_bib25","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3390\/cells11111795","article-title":"Poloxamer 407 induces hypertriglyceridemia but decreases atherosclerosis in Ldlr(-\/-) mice","volume":"11","author":"Peng","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jlr.2025.100763_bib26","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1038\/s41467-023-39311-w","article-title":"Modeling and therapeutic targeting of inflammation-induced hepatic insulin resistance using human iPSC-derived hepatocytes and macrophages","volume":"14","author":"Groeger","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jlr.2025.100763_bib27","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/RES.0000000000000169","article-title":"Recommendation on design, execution, and reporting of animal atherosclerosis studies: a scientific statement from the American heart association","volume":"121","author":"Daugherty","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2025.100763_bib28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1126\/science.275.5298.391","article-title":"A\u00a0mouse model with features of familial combined hyperlipidemia","volume":"275","author":"Masucci-Magoulas","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jlr.2025.100763_bib29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/cvr\/cvv192","article-title":"Aggravated restenosis and atherogenesis in ApoCIII transgenic mice but lack of protection in ApoCIII knockouts: the effect of authentic triglyceride-rich lipoproteins with and without ApoCIII","volume":"107","author":"Li","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jlr.2025.100763_bib30","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/eurheartj\/ehab820","article-title":"Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk","volume":"43","author":"Tardif","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jlr.2025.100763_bib31","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/ATVBAHA.111.230979","article-title":"CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis","volume":"31","author":"Poitou","year":"2011","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2025.100763_bib32","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/ATVBAHA.120.315886","article-title":"Nonclassical monocytes (CD14dimCD16+) are associated with carotid intima-media thickness progression for men but not women: the multi-ethnic study of atherosclerosis","volume":"41","author":"Feinstein","year":"2021","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2025.100763_bib33","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/CIRCRESAHA.124.324457","article-title":"Monocyte single-cell multimodal profiling in cardiovascular disease risk States","volume":"135","author":"Bashore","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2025.100763_bib34","doi-asserted-by":"crossref","first-page":"H109","DOI":"10.1152\/ajpheart.00137.2013","article-title":"Postprandial VLDL lipolysis products increase monocyte adhesion and lipid droplet formation via activation of ERK2 and NFkappaB","volume":"306","author":"den Hartigh","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jlr.2025.100763_bib35","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2025.100763_bib36","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","article-title":"Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation","volume":"128","author":"Varbo","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2025.100763_bib37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1373\/clinchem.2018.294926","article-title":"Low-Grade inflammation in the association between mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis: a study of more than 115000 individuals from the general population","volume":"65","author":"Hansen","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jlr.2025.100763_bib38","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.celrep.2015.08.020","article-title":"Triglyceride-rich lipoproteins modulate the distribution and extravasation of Ly6C\/Gr1(low) monocytes","volume":"12","author":"Saja","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.jlr.2025.100763_bib39","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jlr.2025.100763_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41590-019-0548-1","article-title":"Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation","volume":"21","author":"Zewinger","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jlr.2025.100763_bib41","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/CIRCULATIONAHA.105.591743","article-title":"Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells","volume":"113","author":"Kawakami","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2025.100763_bib42","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41590-023-01423-2","article-title":"Apolipoprotein C3 induces inflammasome activation only in its delipidated form","volume":"24","author":"Hsu","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jlr.2025.100763_bib43","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMoa2402309","article-title":"Olezarsen for hypertriglyceridemia in patients at high cardiovascular risk","volume":"390","author":"Bergmark","year":"2024","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2025.100763_bib44","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1172\/JCI127308","article-title":"Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes","volume":"129","author":"Kanter","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2025.100763_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158414","article-title":"Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering","volume":"7","author":"Ramms","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jlr.2025.100763_bib46","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1093\/eurjpc\/zwaa152","article-title":"Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: atherosclerosis Risk in Communities (ARIC) study","volume":"29","author":"Hussain","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.jlr.2025.100763_bib47","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa1715944","article-title":"Volanesorsen and triglyceride levels in familial chylomicronemia syndrome","volume":"381","author":"Witztum","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2025.100763_bib48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Crosby","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2025.100763_bib49","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1194\/jlr.P600011-JLR200","article-title":"Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions","volume":"48","author":"Zheng","year":"2007","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2025.100763_bib50","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/ATVBAHA.117.309007","article-title":"Apolipoprotein C-III levels and incident coronary artery disease risk: the EPIC-norfolk prospective population study","volume":"37","author":"van Capelleveen","year":"2017","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2025.100763_bib51","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm.4390","article-title":"A\u00a0human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels","volume":"23","author":"Khetarpal","year":"2017","journal-title":"Nat. Med."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227525000239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227525000239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T12:12:09Z","timestamp":1745323929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227525000239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0022227525000239"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100763","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Foamy monocytes and atherogenesis in mice with combined hyperlipidemia and effects of antisense knockdown of apoCIII","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"100763"}}